Last update 01 Nov 2024

Immunomedics GmbH

Subsidiary Company|
Germany
|
www.immunomedics.com

Overview

Related

2
Drugs associated with Immunomedics GmbH
99mTc-Sulesomab
Target
CEACAM6
Mechanism
CEACAM6 inhibitors
Active Org.
Australian Nuclear Science & Technology OrganisationAustralian Nuclear Science & Technology Organisation
Originator Org.
Immunomedics, Inc.Immunomedics, Inc.
Active Indication
Osteomyelitis
Inactive Indication
Diabetic foot ulcer
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date14 Feb 1997
Arcitumomab technetium-99m
Target
CEA
Mechanism
CEA inhibitors
Active Org.-
Originator Org.
Immunomedics, Inc.Immunomedics, Inc.
Active Indication-
Inactive Indication
Colorectal Cancer
Drug Highest PhaseWithdrawn
First Approval Ctry. / Loc.
EU [+3]
First Approval Date04 Oct 1996
100 Clinical Results associated with Immunomedics GmbH
Login to view more data
0 Patents (Medical) associated with Immunomedics GmbH
Login to view more data
100 Deals associated with Immunomedics GmbH
Login to view more data
100 Translational Medicine associated with Immunomedics GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Arcitumomab technetium-99m
 ( CEA )		Colorectal Cancer
More
Withdrawn
99mTc-Sulesomab
 ( CEACAM6 )		Diabetic foot ulcer
More
Withdrawn
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free